These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8708614)

  • 21. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta receptor blockade in heart failure: a new look at an old topic].
    Klein W
    Wien Med Wochenschr; 1996; 146(5):96-7. PubMed ID: 8686329
    [No Abstract]   [Full Text] [Related]  

  • 23. Unreliability of the %VO2 reserve versus %heart rate reserve relationship for aerobic effort relative intensity assessment in chronic heart failure patients on or off beta-blocking therapy.
    Mezzani A; Corrà U; Giordano A; Cafagna M; Adriano EP; Giannuzzi P
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):92-8. PubMed ID: 17301633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does beta-blocker treatment influence central sleep apnoea?
    Köhnlein T; Welte T
    Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe heart failure. Carvedilol lowers mortality].
    MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac function and heart failure.
    Wagoner LE; Starling RC; O'Connor CM
    J Am Coll Cardiol; 2006 Jun; 47(11 Suppl):D18-22. PubMed ID: 16750716
    [No Abstract]   [Full Text] [Related]  

  • 27. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does carvedilol have antiarrhythmic properties?
    Naccarelli GV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
    [No Abstract]   [Full Text] [Related]  

  • 29. [Patient with heart failure. Beta blockage becomes mandatory].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(36):14-6. PubMed ID: 11021061
    [No Abstract]   [Full Text] [Related]  

  • 30. Heart failure therapy in evolution.
    Chatterjee K
    Circulation; 1996 Dec; 94(11):2689-93. PubMed ID: 8941088
    [No Abstract]   [Full Text] [Related]  

  • 31. [Angiotensin receptor blockers in heart failure. CHARM Study].
    Kochsiek K
    Internist (Berl); 2004 Sep; 45(9):1063-7. PubMed ID: 15309315
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-blocker trials seem to be in conflict.
    SoRelle R
    Circulation; 2001 Jun; 103(23):E9049-50. PubMed ID: 11401953
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
    de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
    Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol.
    Frishman WH
    Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
    Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience.
    Lainscak M; Moullet C; Schön N; Tendera M
    Int J Cardiol; 2007 Nov; 122(2):149-55. PubMed ID: 17804098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure.
    Fragasso G; Salerno A; Margonato A
    Am J Cardiol; 2008 Aug; 102(4):506-7. PubMed ID: 18678315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.